Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2005

01-06-2005 | Article

Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome

Authors: F. Gutiérrez, M. Masiá, J. C. Rodríguez, C. Mirete, B. Soldán, S. Padilla, I. Hernández, G. Royo, A. Martin-Hidalgo

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2005

Login to get access

Abstract

Community-acquired pneumonia (CAP) of mixed etiology has increasingly been appreciated in the literature, but its clinical significance remains unknown. The aim of this analysis was to describe the prevalence, clinical characteristics, and outcome of CAP of mixed etiology. Data were obtained from a 2-year prospective study of consecutive patients with CAP in whom an extensive microbiological workup was performed. Predefined strict criteria were used to establish the etiology. A total of 493 patients were included. A single pathogen was detected in 222 (45%) cases and two or more pathogens in 28 (5.7%) cases. Mixed infections were seen across all age groups and in patients treated both in hospital and as outpatients. The most frequent combinations of pathogens were those of a bacterium plus an “atypical” organism (28.6%) and of two bacterial organisms (28.6%). Compared with patients with monomicrobial pneumonia, patients with mixed pneumonia were more likely to have underlying conditions (64% vs. 45%, p=0.04) and dementia (25% vs. 10%, p=0.02). The incidence of a defined series of complications was higher in patients with mixed pneumonia (39.3% vs. 18.6%; OR=2.84; p=0.02). Community-acquired pneumonia of mixed etiology is uncommon. Patients with mixed pneumonia are more likely to have underlying medical conditions, and they may have a more severe course of disease.
Literature
1.
go back to reference Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347–382PubMed Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347–382PubMed
2.
go back to reference Mandell LA, Bartlett JG, Dowel SF, File TM Jr, Musher DM, Whitney C (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37:1405–1433CrossRefPubMed Mandell LA, Bartlett JG, Dowel SF, File TM Jr, Musher DM, Whitney C (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37:1405–1433CrossRefPubMed
3.
go back to reference Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martínez F, Marrie TJ, Plouffe JF, Ramírez J, Sarosi GA, Torres A, Wilson R, Yu VL (2001) American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMed Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martínez F, Marrie TJ, Plouffe JF, Ramírez J, Sarosi GA, Torres A, Wilson R, Yu VL (2001) American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMed
4.
go back to reference Niederman MS, McCombs J, Unger A, Kumar A, Popovian R (1998) The cost of treating community-acquired pneumonia. Clin Ther 20:820–836CrossRefPubMed Niederman MS, McCombs J, Unger A, Kumar A, Popovian R (1998) The cost of treating community-acquired pneumonia. Clin Ther 20:820–836CrossRefPubMed
5.
go back to reference Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, Kallinen S, Sten M, Tarkiainen A, Ronnberg PR, Kleemola M, Makela PH, Leinonen M (1998) Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 17:986–991CrossRefPubMed Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, Kallinen S, Sten M, Tarkiainen A, Ronnberg PR, Kleemola M, Makela PH, Leinonen M (1998) Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 17:986–991CrossRefPubMed
6.
go back to reference Kauppinen MT, Herva E, Kujala P, Leinonen M, Saikku P, Syrjala H (1995) The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 172:1330–1335PubMed Kauppinen MT, Herva E, Kujala P, Leinonen M, Saikku P, Syrjala H (1995) The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 172:1330–1335PubMed
7.
go back to reference Lieberman D, Schlaeffer F, Boldur I, Leberman D, Horowitz S, Friedman MG, Leiononen M, Horovitz O, Manor E, Porath (1996) Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one-year prospective study of 346 consecutive patients. Thorax 51:179–184PubMed Lieberman D, Schlaeffer F, Boldur I, Leberman D, Horowitz S, Friedman MG, Leiononen M, Horovitz O, Manor E, Porath (1996) Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one-year prospective study of 346 consecutive patients. Thorax 51:179–184PubMed
8.
go back to reference Bates JH, Campbell GD, Barron AL, McCracken GA, Morgan PN, Moses EB, Davis CM (1992) Microbial etiology of acute pneumonia in hospitalized patients. Chest 101:1005–1012PubMed Bates JH, Campbell GD, Barron AL, McCracken GA, Morgan PN, Moses EB, Davis CM (1992) Microbial etiology of acute pneumonia in hospitalized patients. Chest 101:1005–1012PubMed
9.
go back to reference Burman LA, Trollfors B, Andersson B, Henrichsen J, Juto P, Kallings I, Lagergard T, Mollby R, Norrby R (1991) Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 163:1087–1093PubMed Burman LA, Trollfors B, Andersson B, Henrichsen J, Juto P, Kallings I, Lagergard T, Mollby R, Norrby R (1991) Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis 163:1087–1093PubMed
10.
go back to reference Gleason PP (2002) The emerging role of atypical pathogens in community-acquired pneumonia. Pharmacotherapy 22 (1 Pt 2):2–11CrossRef Gleason PP (2002) The emerging role of atypical pathogens in community-acquired pneumonia. Pharmacotherapy 22 (1 Pt 2):2–11CrossRef
11.
go back to reference Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P (2001) Study of community-acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56:296–301PubMed Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P (2001) Study of community-acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56:296–301PubMed
12.
go back to reference Plouffe JF (2000) Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis 31 (Suppl 2):35–39CrossRef Plouffe JF (2000) Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis 31 (Suppl 2):35–39CrossRef
13.
go back to reference Mufson MA, Stanek RJ (1999) Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997. Am J Med 107 (Suppl 1A):34–43CrossRef Mufson MA, Stanek RJ (1999) Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997. Am J Med 107 (Suppl 1A):34–43CrossRef
14.
go back to reference Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, Marco MA, Torres A, Mensa J (2003) Addition of a macrolide to a β-lactam based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 36:396–398CrossRefPubMed Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, Marco MA, Torres A, Mensa J (2003) Addition of a macrolide to a β-lactam based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 36:396–398CrossRefPubMed
15.
go back to reference Waterer GW, Somes GW, Wunderink RG (2001) Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161:1837–1842CrossRefPubMed Waterer GW, Somes GW, Wunderink RG (2001) Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161:1837–1842CrossRefPubMed
16.
go back to reference Berntsson E, Blomberg J, Lagergard T, Trollfors B (1985) Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol 4:268–272PubMed Berntsson E, Blomberg J, Lagergard T, Trollfors B (1985) Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol 4:268–272PubMed
17.
go back to reference Berntsson E, Lagergard T, Strannegard O, Trollfors B (1986) Etiology of community-acquired pneumonia in out-patients. Eur J Clin Microbiol 5:446–447PubMed Berntsson E, Lagergard T, Strannegard O, Trollfors B (1986) Etiology of community-acquired pneumonia in out-patients. Eur J Clin Microbiol 5:446–447PubMed
18.
go back to reference Blanquer J, Blanquer R, Borras R, Nauffal D, Morales P, Menendez R, Subias I, Herrero L, Redon J, Pascual J (1991) Aetiology of community-acquired pneumonia in Valencia, Spain. A multicentre prospective study. Thorax 46:508–511PubMed Blanquer J, Blanquer R, Borras R, Nauffal D, Morales P, Menendez R, Subias I, Herrero L, Redon J, Pascual J (1991) Aetiology of community-acquired pneumonia in Valencia, Spain. A multicentre prospective study. Thorax 46:508–511PubMed
19.
go back to reference Bochud PY, Moser F, Erard P, Verdon F, Studer JP, Villard G, Cosendai A, Cotting M, Heim F, Tissot J, Strub Y, Pazeller M, Saghafi L, Wenger A, Germann D, Matter L, Bille J, Pfister L, Francioli P (2001) Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) 80:75–87CrossRef Bochud PY, Moser F, Erard P, Verdon F, Studer JP, Villard G, Cosendai A, Cotting M, Heim F, Tissot J, Strub Y, Pazeller M, Saghafi L, Wenger A, Germann D, Matter L, Bille J, Pfister L, Francioli P (2001) Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) 80:75–87CrossRef
20.
go back to reference Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN (1996) Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 101:508–515CrossRefPubMed Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN (1996) Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 101:508–515CrossRefPubMed
21.
go back to reference Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF (1997) Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 157:1709–1718CrossRefPubMed Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF (1997) Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 157:1709–1718CrossRefPubMed
22.
go back to reference Thom DH, Grayston JT, Campbell LA, Kuo CC, Diwan VK, Wang SE (1994) Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infect Dis 13:785–792PubMed Thom DH, Grayston JT, Campbell LA, Kuo CC, Diwan VK, Wang SE (1994) Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infect Dis 13:785–792PubMed
23.
go back to reference Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250PubMed Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250PubMed
24.
go back to reference Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, Bartolomé M, Balanzó X (2000) Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 15:757–763 Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, Bartolomé M, Balanzó X (2000) Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 15:757–763
25.
go back to reference Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, Yee YC, Rihs JD, Vickers RM (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69:307–316PubMed Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, Yee YC, Rihs JD, Vickers RM (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69:307–316PubMed
26.
go back to reference Almirall J, Morato I, Riera F, Verdaguer A, Priu R, Coll P, Vidal J, Murguí L, Valls F, Catalan F (1993) Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection. A prospective multicentre study. Eur Respir J 6:14–18 Almirall J, Morato I, Riera F, Verdaguer A, Priu R, Coll P, Vidal J, Murguí L, Valls F, Catalan F (1993) Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection. A prospective multicentre study. Eur Respir J 6:14–18
27.
go back to reference Marrie TJ, Durant H, Yates L (1989) Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 11:586–599PubMed Marrie TJ, Durant H, Yates L (1989) Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 11:586–599PubMed
28.
go back to reference McConnell CT Jr, Plouffe JF, File TM, Mueller CF, Wong KH, Skelton SK, Marston BJ, Breiman RF, for the CBPIS Study Group (1994) Radiographic appearances of Chlamydia pneumoniae (TWAR strain) respiratory infections. Radiology 192:819–824PubMed McConnell CT Jr, Plouffe JF, File TM, Mueller CF, Wong KH, Skelton SK, Marston BJ, Breiman RF, for the CBPIS Study Group (1994) Radiographic appearances of Chlamydia pneumoniae (TWAR strain) respiratory infections. Radiology 192:819–824PubMed
29.
go back to reference Marrie TJ, Peeling RW, Reid T, De Carolis E, and the Canadian Community-Acquired Pneumonia Investigators (2003) Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 21:779–784 Marrie TJ, Peeling RW, Reid T, De Carolis E, and the Canadian Community-Acquired Pneumonia Investigators (2003) Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 21:779–784
30.
go back to reference Bakaletz LO (1995) Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 3:110–114 Bakaletz LO (1995) Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 3:110–114
31.
go back to reference Schwarzmann SW, Adler JL, Sullivan RJ (1971) Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Arch Intern Med 127:1037–1041CrossRefPubMed Schwarzmann SW, Adler JL, Sullivan RJ (1971) Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Arch Intern Med 127:1037–1041CrossRefPubMed
32.
go back to reference Madhi SA, Klugman KP, and the Vaccine Trialist Group (2004) A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10:811–813CrossRefPubMed Madhi SA, Klugman KP, and the Vaccine Trialist Group (2004) A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10:811–813CrossRefPubMed
33.
go back to reference Rosón B, Fernández-Sabé Carratalá J, Verdaguer R, Dorca J, Manresa F, Gudiol F (2004) Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 38:222–226PubMed Rosón B, Fernández-Sabé Carratalá J, Verdaguer R, Dorca J, Manresa F, Gudiol F (2004) Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 38:222–226PubMed
34.
go back to reference Domínguez J, Blanco S, Rodrigo C, Azuara M, Gali N, Mainou A, Esteve A, Castellvi A, Prat C, Matas L, Ausina V (2003) Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol 41:2161–2163 Domínguez J, Blanco S, Rodrigo C, Azuara M, Gali N, Mainou A, Esteve A, Castellvi A, Prat C, Matas L, Ausina V (2003) Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol 41:2161–2163
35.
go back to reference Faden H, Heimerl M, Varma C, Goodman G, Winkelstein P (2002) Urinary excretion of pneumococcal cell wall polysaccharide in children. Pediatr Infect Dis J 21:791–793PubMed Faden H, Heimerl M, Varma C, Goodman G, Winkelstein P (2002) Urinary excretion of pneumococcal cell wall polysaccharide in children. Pediatr Infect Dis J 21:791–793PubMed
36.
go back to reference Murdoch DR, Laing RT, Cook JM (2003) The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD. Clin Infect Dis 37:153–154CrossRefPubMed Murdoch DR, Laing RT, Cook JM (2003) The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD. Clin Infect Dis 37:153–154CrossRefPubMed
37.
go back to reference Dudas V, Hopefl A, Jacobs R, Guglielmo BJ (2000) Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother 34:446–452CrossRefPubMed Dudas V, Hopefl A, Jacobs R, Guglielmo BJ (2000) Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother 34:446–452CrossRefPubMed
38.
go back to reference Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ (1999) Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 159:2562–2572CrossRefPubMed Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ (1999) Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 159:2562–2572CrossRefPubMed
39.
go back to reference Houck PM, MacLehose RF, Niederman MS, Lowery JK (2001) Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997. Chest 119:1420–1426CrossRefPubMed Houck PM, MacLehose RF, Niederman MS, Lowery JK (2001) Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997. Chest 119:1420–1426CrossRefPubMed
40.
go back to reference Stahl JE, Barza M, DesJardin J, Martin R, Eckman MH (1999) Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 159:2576–2580CrossRefPubMed Stahl JE, Barza M, DesJardin J, Martin R, Eckman MH (1999) Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 159:2576–2580CrossRefPubMed
41.
go back to reference File TM, Mandell LA (2003) What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Clin Infect Dis 36:396–398CrossRefPubMed File TM, Mandell LA (2003) What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Clin Infect Dis 36:396–398CrossRefPubMed
Metadata
Title
Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome
Authors
F. Gutiérrez
M. Masiá
J. C. Rodríguez
C. Mirete
B. Soldán
S. Padilla
I. Hernández
G. Royo
A. Martin-Hidalgo
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-1346-2

Other articles of this Issue 6/2005

European Journal of Clinical Microbiology & Infectious Diseases 6/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine